Sagimet Biosciences Inc.

Filed a patent for "combination therapies of fasn inhibitors with thyroid hormone receptor agonists" on Tue, June 20, 2023

Filed a patent for "heterocyclic modulators of lipid synthesis" on Thu, December 5, 2024

Filed a patent for "methods for prediction of treatment response in non-alcoholic fatty liver disease" on Fri, May 10, 2024

Filed a patent for "methods for prediction of treatment response in non-alcoholic fatty liver disease" on Thu, October 20, 2022

Filed a patent for "heterocyclic modulators of lipid synthesis" on Thu, December 21, 2023